Category
blog
-
2023
-
FDA Approves Austedo XR Extended-Release Tablets for Huntington’s Disease
-
Theravance, Viatris Seek to Block Copies of COPD Drug
-
EU Authorizes CSL’s Gene Therapy for Hemophilia B
-
Alzheimer’s Antibody Therapy from Eli Lilly Granted US FDA Breakthrough Therapy designation
-
FDA creates task force to fast track COVID-19 drugs registration
-
First-of-its-kind study examines the impact of cannabis use on surgical patients’ post-procedure healthcare needs
-
FDA Approves Sanofi and Sobi’s Altuviiio for Hemophilia A
-
Dr. Reddy’s bolsters US generics business with $105M deal to buy Mayne Pharma assets
-
FDA Accepts IND and Grants Priority Review for SpringWorks Desmoid Tumors Therapeutic
-
FDA Offers Advice on Macular Degeneration Drug Trials